| Ident. | Authors (with country if any) | Title |
|---|
| 000080 (2020) |
Aimee Coscarart [États-Unis] ; Julianna Martel [États-Unis] ; Michael P. Lee [États-Unis] ; Alun R. Wang [États-Unis] | Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus. |
| 000088 (2020) |
Tingting Jiang [République populaire de Chine] ; Xiang-Sheng Chen [République populaire de Chine] | Outcome Impacts Due to Pathogen-Specific Antimicrobial Resistance: A Narrative Review of Published Literature |
| 000116 (2020) |
Xiaoyan Si ; Peng Song ; Jun Ni ; Mingyi Di ; Chunxia He ; Li Zhang ; Xiaowei Liu ; Yue Li ; Hanping Wang ; Xiaoxiao Guo ; Jiaxin Zhou ; Lian Duan ; Xu Yang ; Mengzhao Wang ; Li Zhang | Management of immune checkpoint inhibitor‐related adverse events: A review of case reports |
| 000120 (2020) |
Célia Faustino ; Lídia Pinheiro | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy |
| 000234 (2020) |
Houshuang Zhang ; Zhonghua Wang ; Jingwei Huang ; Jie Cao ; Yongzhi Zhou ; Jinlin Zhou | A Novel Thioredoxin-Dependent Peroxiredoxin (TPx-Q) Plays an Important Role in Defense Against Oxidative Stress and Is a Possible Drug Target in Babesia microti |
| 000332 (2019) |
Ozge Alvur [Turquie] ; Onur Tokgun [Turquie] ; Yasemin Baygu [Turquie] ; Nilgun Kabay [Turquie] ; Yasar Gok [Turquie] ; Hakan Akca [Turquie] | The triazole linked galactose substituted dicyano compound can induce autophagy in NSCLC cell lines. |
| 000344 (2019) |
Cindy S. Chu [Thaïlande, Royaume-Uni] ; Germana Bancone [Thaïlande, Royaume-Uni] ; Nay Lin Soe [Thaïlande] ; Verena I. Carrara [Thaïlande, Suisse] ; Gornpan Gornsawun [Thaïlande] ; François Nosten [Thaïlande, Royaume-Uni] | The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis |
| 000359 (2019) |
Kun-Lin Lu [Taïwan] ; Ming-Ying Wu [Taïwan] ; Chi-Hui Wang [Taïwan] ; Chuang-Wei Wang [Taïwan] ; Shuen-Iu Hung [Taïwan] ; Wen-Hung Chung [Taïwan, République populaire de Chine] ; Chun-Bing Chen [Taïwan, République populaire de Chine] | The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus |
| 000406 (2019) |
J. C. Gomez-Verjan [Mexique] ; R. Ramírez-Aldana [Mexique] ; M. U. Pérez-Zepeda [Mexique] ; R. Quiroz-Baez [Mexique] ; A. Luna-L Pez [Mexique] ; L. M. Gutierrez Robledo [Mexique] | Systems biology and network pharmacology of frailty reveal novel epigenetic targets and mechanisms |
| 000420 (2019) |
Nesrine B. Zitouni ; Jean-Philippe Arnault ; Ali Dadban ; Christophe Attencourt [France] ; Catherine C. Lok ; Guillaume Chaby | Subacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review. |
| 000421 (2019) |
A L Marano [États-Unis] ; J M Clarke [États-Unis] ; M A Morse [États-Unis] ; A. Shah [États-Unis] ; W. Barrow [États-Unis] ; M A Selim [États-Unis] ; R P Hall [États-Unis] ; A R Cardones [États-Unis] | Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy. |
| 000429 (2019) |
Ye Zi ; Yao Yi-An ; Ji Bing ; Lai Yan ; Tong Jing ; Guan Chun-Yu ; Ping Fan ; Lin Hao ; Tang Jia-Ni ; Hou Han-Jin ; Chen Fei ; Liu Xue-Bo | Sirt6-induced autophagy restricted TREM-1-mediated pyroptosis in ox-LDL-treated endothelial cells: relevance to prognostication of patients with acute myocardial infarction |
| 000462 (2019) |
Peter Korsten ; Gerhard A. Müller ; Jan-Gerd Rademacher ; Michael Zeisberg ; Björn Tampe | Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments |
| 000509 (2019) |
Li Li [République populaire de Chine] ; Yubo Wang [République populaire de Chine] ; Lin Jiao [République populaire de Chine] ; Caiyu Lin [République populaire de Chine] ; Conghua Lu [République populaire de Chine] ; Kejun Zhang [République populaire de Chine] ; Chen Hu [République populaire de Chine] ; Junyi Ye [République populaire de Chine] ; Dadong Zhang [République populaire de Chine] ; Haiyan Wu [République populaire de Chine] ; Mingxia Feng [République populaire de Chine] ; Yong He [République populaire de Chine] | Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer. |
| 000530 (2019) |
Cassandra Calabrese [États-Unis] ; Laura C. Cappelli [États-Unis] ; Marie Kostine [France] ; Elizabeth Kirchner [États-Unis] ; Tawnie Braaten [États-Unis] ; Leonard Calabrese [États-Unis] | Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature |
| 000553 (2019) |
Celia Nieto [Espagne] ; Ariana Centa [Espagne] ; Jesús A. Rodríguez-Rodríguez [Espagne] ; Atanasio Pandiella [Espagne] ; Eva M. Martín Del Valle [Espagne] | Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors |
| 000569 (2019) |
Sidharth Sonthalia ; Parul Aggarwal | Oral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology |
| 000609 (2019) |
Toshiki Etani ; Taku Naiki ; Aya Naiki-Ito ; Takayoshi Suzuki [Japon] ; Keitaro Iida ; Satoshi Nozaki ; Hiroyuki Kato ; Yuko Nagayasu ; Shugo Suzuki ; Noriyasu Kawai ; Takahiro Yasui ; Satoru Takahashi | NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy |
| 000639 (2019) |
Katherine A. Roach [États-Unis] ; Aleksandr B. Stefaniak [États-Unis] ; Jenny R. Roberts [États-Unis] | Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease |
| 000653 (2019) |
Marina Elena Cazzaniga [Italie] ; Romano Danesi [Italie] ; Corrado Girmenia [Italie] ; Pietro Invernizzi [Italie] ; Alessandra Elvevi [Italie] ; Massimo Uguccioni [Italie] | Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success |
| 000693 (2019) |
Xiu Chen [République populaire de Chine] ; Di Xu [République populaire de Chine] ; Xingjiang Li [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Weilin Xu [République populaire de Chine] ; Junchen Hou [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Jinhai Tang [République populaire de Chine] | Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future |
